Reply:
Tahany Awad, Kristian Thorlund, Goran Hauser, Davor Stimac, Mahasen Mabrouk, Christian Gluud – 26 October 2010
Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites
Mevlut Kurt – 26 October 2010
Beta‐blockers have no effect on outcomes in patients with cirrhosis and severe infections
Arnaud Galbois, Vincent Das, Dominique Thabut, Eric Maury, Hafid Ait‐Oufella, Chantal Housset, Bertrand Guidet – 26 October 2010
Hepatitis C pharmacogenetics: State of the art in 2010
Nezam H. Afdhal, John G. McHutchison, Stefan Zeuzem, Alessandra Mangia, Jean‐Michel Pawlotsky, Jeffrey S. Murray, Kevin V. Shianna, Yasuhito Tanaka, David L. Thomas, David R. Booth, David B. Goldstein, for the Pharmacogenetics and Hepatitis C Meeting Participants – 26 October 2010 – In 2009, a correlated set of polymorphisms in the region of the interleukin‐28B (IL28B) gene were associated with clearance of genotype 1 hepatitis C virus (HCV) in patients treated with pegylated interferon‐alfa and ribavirin.
Mining for a diagnosis of Wilson's disease in children: Genetics, score, and ore
Richard A. Rosencrantz, Michael L. Schilsky – 26 October 2010
Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin‐28B rs12979860 Haplotype
Matthew L. Albert, Armanda Casrouge, Stéphane Chevaliez, Christophe Hézode, Isabelle Rosa, Philippe Renard, Vincent Mallet, Arnaud Fontanet, Jean‐Michel Pawlotsky, Stanislas Pol – 26 October 2010
Quantitation of pretreatment serum interferon‐γ–inducible protein‐10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response
Jama M. Darling, Jeroen Aerssens, Gregory Fanning, John G. McHutchison, David B. Goldstein, Alexander J. Thompson, Kevin V. Shianna, Nezam H. Afdhal, Michael L. Hudson, Charles D. Howell, Willem Talloen, Jacques Bollekens, Mieke De Wit, Annick Scholliers, Michael W. Fried – 26 October 2010 – Polymorphisms of the IL28B gene are highly associated with sustained virological response (SVR) in patients with chronic hepatitis C treated with peginterferon and ribavirin. Quantitation of interferon‐γ–inducible protein‐10 (IP‐10) may also differentiate antiviral response.
Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C Virus 1 year after liver transplantation
Pinelopi Manousou, Amar P. Dhillon, Graziela Isgro, Vincenza Calvaruso, T.V. Luong, Emmanuel Tsochatzis, E. Xirouchakis, G. Kalambokis, Timothy J. Cross, N. Rolando, James O'Beirne, David Patch, D. Thornburn, Andrew K. Burroughs – 21 October 2010 – Clinical outcomes of recurrent hepatitis C virus after liver transplantation are difficult to predict. We evaluated collagen proportionate area (CPA), a quantitative histological index, at 1 year with respect to the first episode of clinical decompensation.
Domino versus deceased donor liver transplantation: Association with early graft function and perioperative bleeding
Miguel Bispo, Paulo Marcelino, Hugo Pinto Marques, Américo Martins, Rui Perdigoto, Maria João Aguiar, Luís Mourão, Eduardo Barroso – 21 October 2010 – This study sought to evaluate the potential impact of domino liver transplantation (DLT) on initial graft function and early postoperative outcome in patients with cirrhosis in a Portuguese liver transplantation center.